Investigation Report on China's Tacrolimus Market 2021-2025
No. of Pages: 50
Tacrolimus is a macrolide antibiotic and is also a new immunosuppressant. It is available in a variety of dosage forms. The ointment is used for
|
23-Apr-2021
|
2600
|
Investigation Report on China's Trastuzumab Market 2021-2025
No. of Pages: 50
Trastuzumab is a monoclonal antibody used to treat breast cancer and stomach cancer, and is especially used for the treatment of certain HER-2 positive cancers.
|
23-Apr-2021
|
2600
|
Investigation Report on Chinese Clopidogrel Market 2021-2025
No. of Pages: 50
Clopidogrel is a medication that inhibits platelet aggregation and is mainly used to prevent atherosclerotic thrombosis. The original drug, Plavix, is developed by Sanofi. It
|
23-Apr-2021
|
2600
|
Investigation Report on China's Ambroxol Market, 2021-2025
No. of Pages: 50
According to Researcher, the incidence and case fatality rate of respiratory diseases in China are high in recent years. Following cardiovascular and cerebrovascular diseases and
|
09-Apr-2021
|
2600
|
Investigation Report on China's Hydroxychloroquine Market, 2021-2025
No. of Pages: 50
Hydroxychloroquine is commonly used to prevent and treat malaria. The pharmacokinetics of hydroxychloroquine is similar to that of chloroquine. It can be rapidly absorbed in
|
09-Apr-2021
|
2600
|
Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025
No. of Pages: 50
According to Researcher analysis, China’s rapid economic development in the past 30 years has brought about changes in people’s lifestyles, such as a reduction in
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Adalimumab Market, 2021-2025
No. of Pages: 40
In 2010, Adalimumab entered the Chinese market. Its original drug is produced by AbbVie Inc., under the brand name HUMIRA. The sales of HUMIRA is
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Apixaban Market 2021-2025
No. of Pages: 50
Anticoagulation therapy plays an important role in the prevention and treatment of thromboembolic diseases. The two most famous drugs are Rivaroxaban and Apixaban, mainly used
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Bevacizumab Market 2021-2025
No. of Pages: 50
Bevacizumab is the world's first humanized monoclonal antibody for anti-tumor angiogenesis, which can be used to treat colon cancer and other solid tumors. AVASTIN, the
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Budesonide Market 2021-2025
No. of Pages: 50
Budesonide is an adrenal cortex hormone medicine. It is available in different forms, such as inhalant, nasal spray, and so on. The inhalation form is
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Dezocine Market, 2021-2025
No. of Pages: 50
Dezocine is an opioid analgesic that relieves pain. Dezocine was launched in China in 2009 and has been widely used in general anesthesia induction, postoperative
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Pembrolizumab Market, 2021-2025
No. of Pages: 50
Pembrolizumab is a humanized PD-1 monoclonal antibody used for cancer immunotherapy. It currently has the most approved indications, as well as it is used in
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Sevoflurane Market, 2021-2025
No. of Pages: 50
Sevoflurane is an inhalation general anesthetic and also the main inhalation anesthetic at this stage. Inhaled Sevoflurane was originally developed by Abbott and entered the
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Atorvastatin Market 2021-2025
No. of Pages: 50
Atorvastatin is a common drug used to lower blood cholesterol levels. Its original drug, Lipitor (developed by Pfizer Inc), entered the Chinese market in 1999.
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Cefoperazone Sodium and Sulbactam Sodium Market 2021-2025
No. of Pages: 50
Cefoperazone Sodium and Sulbactam Sodium is an injectable antibiotic. The original drug is SULPERAZON, developed by Pfizer. In addition to Pfizer, the other main manufacturers
|
09-Apr-2021
|
2600
|
Investigation Report on Chinese Hydroxychloroquine(HCQ) Market, 2020-2024
No. of Pages: 50
Description
Hydroxychloroquine(HCQ) is an antimalarial drug. It treats malaria by killing the parasites that cause the disease. Hydroxychloroquine was listed in the United States in 1955,
|
20-Oct-2020
|
2600
|
Investigation Report on Chinese Rituximab Market, 2020-2024
No. of Pages: 50
Description
Rituximab (Roche's trade name: MabThera/Rituxan) is a human-mouse chimeric anti-CD20 monoclonal antibody that was approved for the treatment of tumors in 1997. With the deep
|
20-Oct-2020
|
2600
|
Investigation Report on Sevoflurane in China, 2020-2024
No. of Pages: 50
Description
Sevoflurane is an inhaled general anesthetic featured with rapid induction and quick wake-up of patients. It has slight inhibition on circulation, little effect on liver
|
20-Oct-2020
|
2600
|
Research Report on China Express Delivery Industry, 2020-2024
No. of Pages: 60
Description
From 2015 to 2020, the frequency of online shopping applications of Chinese Internet users increased from 56.00% to 79.7%. Online shopping has become one of
|
20-Oct-2020
|
2600
|
Research Report on China's New Energy Vehicle Drive Motor Industry, 2020-2024
No. of Pages: 50
Description
With government support and technological progress, the global electric vehicle market is developing rapidly. The production volume of global electric vehicle increased rapidly from only
|
20-Oct-2020
|
2600
|
